Noor Al-Amana is the first company to launch the antiviral product “Molnupiravir”, which is used for COVID-19 diseases, in Libya.
Noor Al-Amana as exclusive contractor and partner of Eva Pharma ensures complete roll-out and distribution in Libya.
Noor Al-Amana is the first company to launch the antiviral product “Molnupiravir”, which is used for COVID-19 diseases, in Libya.
Noor Al-Amana as exclusive contractor and partner of Eva Pharma ensures complete roll-out and distribution in Libya.